Prevalence of Loss-of-Function FTO Mutations in Lean and Obese Individuals

OBJECTIVE Single nucleotide polymorphisms (SNPs) in intron 1 of fat mass– and obesity-associated gene (FTO) are strongly associated with human adiposity, whereas Fto−/− mice are lean and Fto+/− mice are resistant to diet-induced obesity. We aimed to determine whether FTO mutations are disproportionately represented in lean or obese humans and to use these mutations to understand structure-function relationships within FTO. RESEARCH DESIGN AND METHODS We sequenced all coding exons of FTO in 1,433 severely obese and 1,433 lean individuals. We studied the enzymatic activity of selected nonsynonymous variants. RESULTS We identified 33 heterozygous nonsynonymous variants in lean (2.3%) and 35 in obese (2.4%) individuals, with 8 mutations unique to the obese and 11 unique to the lean. Two novel mutations replace absolutely conserved residues: R322Q in the catalytic domain and R96H in the predicted substrate recognition lid. R322Q was unable to catalyze the conversion of 2-oxoglutarate to succinate in the presence or absence of 3-methylthymidine. R96H retained some basal activity, which was not enhanced by 3-methylthymidine. However, both were found in lean and obese individuals. CONCLUSIONS Heterozygous, loss-of-function mutations in FTO exist but are found in both lean and obese subjects. Although intron 1 SNPs are unequivocally associated with obesity in multiple populations and murine studies strongly suggest that FTO has a role in energy balance, it appears that loss of one functional copy of FTO in humans is compatible with being either lean or obese. Functional analyses of FTO mutations have given novel insights into structure-function relationships in this enzyme.

[1]  Philippe Froguel,et al.  Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations. , 2009, American journal of human genetics.

[2]  Jens C. Brüning,et al.  Inactivation of the Fto gene protects from obesity , 2009, Nature.

[3]  J. Norris,et al.  Analysis of FTO gene variants with measures of obesity and glucose homeostasis in the IRAS Family Study , 2009, Human Genetics.

[4]  Ellen Kampman,et al.  Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity , 2009, Nature Genetics.

[5]  Chengqi Yi,et al.  Oxidative demethylation of 3‐methylthymine and 3‐methyluracil in single‐stranded DNA and RNA by mouse and human FTO , 2008, FEBS letters.

[6]  P. Froguel,et al.  The FTO Gene Is Associated With Adulthood Obesity in the Mexican Population , 2008, Obesity.

[7]  G. Uhl,et al.  Brain-derived neurotrophic factor and obesity in the WAGR syndrome. , 2008, The New England journal of medicine.

[8]  T. Hansen,et al.  Common nonsynonymous variants in PCSK1 confer risk of obesity , 2008, Nature Genetics.

[9]  L. Chuang,et al.  Common Variation in the Fat Mass and Obesity-Associated (FTO) Gene Confers Risk of Obesity and Modulates BMI in the Chinese Population , 2008, Diabetes.

[10]  Subhajyoti De,et al.  Common variants near MC4R are associated with fat mass, weight and risk of obesity , 2008, Nature Genetics.

[11]  Philippe Froguel,et al.  Common genetic variation near MC4R is associated with waist circumference and insulin resistance , 2008, Nature Genetics.

[12]  L. V. Van Gaal,et al.  Variants in the FTO gene are associated with common obesity in the Belgian population. , 2008, Molecular genetics and metabolism.

[13]  C. Magness,et al.  Association of the FTO Gene With BMI , 2008, Obesity.

[14]  Yusuke Nakamura,et al.  Variations in the FTO gene are associated with severe obesity in the Japanese , 2008, Journal of Human Genetics.

[15]  M. McCarthy,et al.  Regulation of Fto/Ftm gene expression in mice and humans. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[16]  Struan F. A. Grant,et al.  Association Analysis of the FTO Gene with Obesity in Children of Caucasian and African Ancestry Reveals a Common Tagging SNP , 2008, PloS one.

[17]  K. Mossman.  The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[18]  G. Siest,et al.  The STANISLAS Cohort: a 10-year follow-up of supposed healthy families. Gene-environment interactions, reference values and evaluation of biomarkers in prevention of cardiovascular diseases , 2008, Clinical chemistry and laboratory medicine.

[19]  Hongyu Zhao,et al.  FTO gene SNPs associated with extreme obesity in cases, controls and extremely discordant sister pairs , 2008, BMC Medical Genetics.

[20]  Harald Grallert,et al.  Genome Wide Association (GWA) Study for Early Onset Extreme Obesity Supports the Role of Fat Mass and Obesity Associated Gene (FTO) Variants , 2007, PloS one.

[21]  Chris P. Ponting,et al.  The Obesity-Associated FTO Gene Encodes a 2-Oxoglutarate-Dependent Nucleic Acid Demethylase , 2007, Science.

[22]  F. Horber,et al.  Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene. , 2007, Human molecular genetics.

[23]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[24]  Beverley Balkau,et al.  Variation in FTO contributes to childhood obesity and severe adult obesity , 2007, Nature Genetics.

[25]  James Strait,et al.  Genome-Wide Association Scan Shows Genetic Variants in the FTO Gene Are Associated with Obesity-Related Traits , 2007, PLoS genetics.

[26]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[27]  J. Hodges,et al.  Hyperphagia, Severe Obesity, Impaired Cognitive Function, and Hyperactivity Associated With Functional Loss of One Copy of the Brain-Derived Neurotrophic Factor (BDNF) Gene , 2006, Diabetes.

[28]  J. Tainer,et al.  Human ABH3 structure and key residues for oxidative demethylation to reverse DNA/RNA damage , 2006, The EMBO journal.

[29]  T. Gudermann,et al.  Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. , 2004, American journal of human genetics.

[30]  S. O’Rahilly,et al.  Minireview: human obesity-lessons from monogenic disorders. , 2003, Endocrinology.

[31]  S. Bhattacharyya,et al.  A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. , 2002, Human molecular genetics.

[32]  R. Dildrop,et al.  The mouse Fused toes (Ft) mutation is the result of a 1.6-Mb deletion including the entire Iroquois B gene cluster , 2002, Mammalian Genome.

[33]  U. Rüther,et al.  Cloning of Fatso (Fto), a novel gene deleted by the Fused toes (Ft) mouse mutation , 1999, Mammalian Genome.

[34]  K. Clément,et al.  A frameshift mutation in human MC4R is associated with a dominant form of obesity , 1998, Nature Genetics.

[35]  S. O’Rahilly,et al.  A frameshift mutation in MC4R associated with dominantly inherited human obesity , 1998, Nature Genetics.

[36]  A. Grüters,et al.  Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans , 1998, Nature Genetics.

[37]  S. O’Rahilly,et al.  Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene , 1997, Nature Genetics.

[38]  B. Balkau,et al.  [An epidemiologic survey from a network of French Health Examination Centres, (D.E.S.I.R.): epidemiologic data on the insulin resistance syndrome]. , 1996, Revue d'epidemiologie et de sante publique.

[39]  E. Poskitt.  Defining childhood obesity: the relative body mass index (BMI) , 1995, Acta paediatrica.

[40]  V. Günzler,et al.  Assay for 2-oxoglutarate decarboxylating enzymes based on the determination of [1-14C]succinate: application to prolyl 4-hydroxylase. , 1990, Analytical biochemistry.